Article Text

Download PDFPDF
Extensive porto-splenic venous thrombosis postsplenectomy in a sickle cell disease: a rare complication
  1. Tamadher Al Barhi1,
  2. Yasser Wali2,3,
  3. Sareyah Al Sibai4 and
  4. Zainab Al Balushi4
  1. 1General Surgery, Oman Medical Speciality Board, Al-Athaiba, Oman
  2. 2Department of Child Health, Sultan Qaboos University, Muscat, Oman
  3. 3Faculty of Medicine, Alexandria University, Alexandria, Egypt
  4. 4Department of Surgery, Sultan Qaboos University Hospital, Muscat, Oman
  1. Correspondence to Dr Yasser Wali; yasser_wali{at}


Hereditary haemoglobinopathies are common disorders in Oman. The most common haematological disorder among Omani population is sickle cell disease (SCD). The spleen is one of the organs that is affected early in the first decade of life in SCD patients. Splenectomy has shown a high success rate in improving the quality of life in SCD patients, through eliminating acute splenic sequestration crises, thus reducing the need for hospital admission and transfusion requirements. One of the rare complications of splenectomy is porto-splenic vein thrombosis. Multiple factors are responsible for this complication including: thermal and mechanical injury during ligation of splenic hilum, sudden increase in the platelet count and large spleen size. We report a rare case of extensive porto-splenic vein thrombosis that responded to early initiation of anticoagulation with resolution of the thrombosis and recanalisation.

  • haematology (incl blood transfusion)
  • paediatric surgery

Statistics from


  • Contributors TAB wrote down the case report and the discussion part with help of SAS who managed the patient in the first admission. YW and ZAB reviewed the case report and the analysis part.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Case reports provide a valuable learning resource for the scientific community and can indicate areas of interest for future research. They should not be used in isolation to guide treatment choices or public health policy.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.